Citi Institute Supply Chain Financing Report: Liquidity Takes Center Stage as Supply Chain Disruption Becomes Norm

Citi Institute Supply Chain Financing Report: Liquidity Takes Center Stage as Supply Chain Disruption Becomes Norm

Key Highlights:

  • Citi Institute’s supply chain financing report reveals corporates are prioritizing liquidity as global trade routes continue to shift and disruption becomes the norm, with 72% ranking releasing trapped liquidity as a top priority.

  • Amidst ongoing disruption, corporate treasurers are focused on digital solutions to improve cash visibility and build resilience, with AI adoption in trade operations nearly tripling to 45% since 2024.

  • The findings suggest the next stage of supply chain strategy will be shaped by treasury priorities including strengthening cash flow, as companies adapt to a new global trade and investment landscape.

LONDON–(BUSINESS WIRE)–
Citi Institute and Citi’s Services business today released a new report, The World Rewired: Shifts in Global Trade and Foreign Direct Investment. The report examines how corporate priorities are evolving as global supply chains mature. As the findings suggest, corporates are placing greater emphasis on working capital, liquidity and cash visibility while trade routes and sourcing relationships continue to change.

According to the data, the conflict in the Middle East as well as elevated oil and refined product prices have kept Citi’s Global Supply Chain Pressure Index at its highest sustained level since 2021-2022. Against that backdrop, corporate treasurers are increasingly focused on extracting the cash that is embedded in their supply chains, creating a liquidity advantage that actively strengthens resilience-building.

72% of global corporates identify releasing trapped liquidity as their top strategic priority for the next 12 months, up from 66% at the start of 2026. For 64% of respondents, discovering how much liquidity is trapped in their supply chains has become a key driver of working capital strategy, compared to 55% earlier in the year.

“For several years the conversation was dominated by resilience through diversification,” said Adoniro Cestari, Global Head of Trade and Working Capital Solutions, Citi Services. “Companies diversified their supplier base and redesigned sourcing strategies to strengthen their operations. Now treasury teams are turning to a related question: where is our cash sitting, and how quickly can it be put to work?”

Global Trade Continues to Grow as Trade Routes Shift

Citi’s payment and receivable flows data show global trade continuing to grow despite disruption. Overall payment flows rose 40% year-on-year in the first half of 2026, with growth recorded across every major region that Citi tracks.

Growth in technology payments led the way at a time when the global AI infrastructure buildout continues to reshape capital flows. Globally, these flows grew by 50% year-on-year, with Asia and Latin America flows increasing by 60% and 58%, respectively. Domestic U.S. flows increased by 37% while cross-border flows from Taiwan to Singapore grew 90% and flows from the U.S. to Taiwan increased by 36%. These domestic and cross-border flows were responsible for a significant portion of the technology sector’s overall growth.

Trade routes are shifting alongside these payment flows. China’s vehicle and parts exports illustrate the pattern clearly: North America once absorbed roughly a third of these shipments, but its share has decreased to about 13% by mid-2026. Africa, by contrast, has emerged as one of the fastest-growing destinations, nearly doubling its share from around 8% in 2022 to above 15% today, while Latin America has become the largest overall gainer in the category.

A similar reorientation is underway in agriculture. Brazil and Argentina have helped Latin America cement itself as China’s dominant agricultural supplier, capturing between a third and nearly half of total import share in recent quarters, respectively.

How Corporates Are Responding to Costs, Tariffs and Disruption

Cost pressures continue to be a key influence on attitudes towards working capital management. Globally, 68% of corporates said increasing input costs was a key factor in shaping their working capital decisions and 59% said elevated interest rates were an influence on their attitudes towards working capital management. Combined, these factors highlight how elevated costs now represent structural rather than cyclical challenges.

Tariff exposure tells a similarly uneven story. It’s a leading motivator for relocating supply chains among corporates in APAC (46%) and Latin America (44%), yet it barely registers in North America, cited by just 2% of respondents there, a reminder of how differently this environment is being felt from region to region.

Interest in digital tools to support working capital performance is also rising. Nearly half of corporates said they are evaluating DLT (Distributed Ledger Technology) and blockchain solutions, and the share using Artificial Intelligence in trade operations has nearly tripled, from 16% in 2024 to 45% today.

“There’s a tendency to read every shock as evidence that globalization is going into reverse,” Cestari said. “The report tells a more nuanced story. Trade, investment and payments flows are still growing, just through different markets and corridors than they did a decade ago. Companies are adapting to that reality while looking for ways to operate more efficiently amid ongoing uncertainty and make better use of their liquidity.”

Taken together, the findings suggest that the next stage of supply chain decision-making will be shaped as much by treasury priorities as operational ones, with companies strengthening cash flow and doubling down on resilience.

The report draws on Citi’s proprietary payments network data, spanning tens of thousands of corporate clients across every major region, together with Citi’s own mid-year survey of more than 700 large corporates and 150 suppliers alongside economic analysis from Citi Research.

About Citi

Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of the United States. Citi does business in more than 180 countries and jurisdictions, providing corporations, governments, investors, institutions and individuals with a broad range of financial products and services.

Additional information may be found at www.citigroup.com | X: @Citi | LinkedIn: www.linkedin.com/company/citi | YouTube: www.youtube.com/citi | Facebook: www.facebook.com/citi

Media Contacts:

Harsha Jethnani

[email protected]

Courtney Tolbert

[email protected]

KEYWORDS: North America United States United Kingdom Europe Canada

INDUSTRY KEYWORDS: Technology Payments Finance Transport Banking Professional Services Digital Cash Management/Digital Assets Logistics/Supply Chain Management Supply Chain Management Retail

MEDIA:

Logo
Logo

Apollo Funds Complete €3 Billion Capital Solution for Bayer

KKR joins Apollo as a minority participant

NEW YORK and LEVERKUSEN, Germany, Sept. 16, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates (“Apollo”) have successfully closed a €3 billion capital solution for Bayer, previously announced on July 10. KKR has joined Apollo as a significant minority participant in the investment.

Under the transaction, Apollo, together with KKR, have invested equity capital into a newly established entity holding Bayer’s long-acting reversible contraceptives (LARC) business. Bayer retains a majority stake in the entity and continues to exercise full operational control over the business; there are no changes to the LARC strategy as a result of the investment.

Apollo Partner Jamshid Ehsani said, “We are proud to serve as a capital partner to Bayer, originating and leading a multi-billion-euro capital solution tailored to their needs. Bayer, a global life sciences leader and iconic German company, represents the types of large, blue-chip companies we serve through our High Grade Capital Solutions business.”

Ehsani added, “Apollo has committed to deploying more than $100 billion in Germany over the coming decade, and Bayer exemplifies the kind of strategic, long-term partnership we seek to build with the country’s most important companies.”

Centerview Partners served as financial advisor to the Apollo Funds. Latham & Watkins LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, and NautaDutilh N.V. are legal counsel to the Apollo Funds.

About Apollo

Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees and the communities we impact, to expand opportunity and achieve positive outcomes. As of June 30, 2026, Apollo had approximately $1.05 trillion of assets under management. To learn more, please visit www.apollo.com.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros. For more information, go to www.bayer.com.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

Contacts:

Apollo

Noah Gunn
Global Head of Investor Relations
(212) 822-0540
[email protected]

Joanna Rose
Global Head of Corporate Communications
(212) 822-0491
[email protected] / [email protected]

KKR

Julia Leeger
+44 20 7839 9800
[email protected]

Bayer

Investor Relations: [email protected]
Corporate Media Relations: [email protected]



HAFNIA LIMITED: Acquisition of an Additional 4.5 Million TORM Shares

HAFNIA LIMITED: Acquisition of an Additional 4.5 Million TORM Shares

SINGAPORE–(BUSINESS WIRE)–
Hafnia Limited (“Hafnia”, the “Company”, OSE ticker code: “HAFNI”, NYSE ticker code: “HAFN”) has agreed to acquire 4,500,000 A shares in TORM plc (“TORM”, CSE ticker code: “TRMD A”, NASDAQ ticker code: “TRMD”) at a price per share of USD 32.25, representing 4.39% of the issued and outstanding share capital of TORM as of the date hereof. Upon completion of this acquisition, Hafnia will hold approximately 18.22% of the issued and outstanding share capital of TORM.

About Hafnia Limited:

Hafnia is one of the world’s leading tanker owners, transporting oil, oil products and chemicals for major national and international oil companies, chemical companies, as well as trading and utility companies.

As owners and operators of around 180 vessels, we offer a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk. Hafnia has offices in Singapore, Copenhagen, Houston, and Dubai and currently employs over 4,000 employees onshore and at sea.

Hafnia is part of the BW Group, an international shipping group involved in oil and gas transportation, floating gas infrastructure, environmental technologies, and deep-water production for over 80 years.

For further information, please contact:

Søren Steenberg Jensen

CEO Hafnia Limited

[email protected]

KEYWORDS: New York United States Norway United Kingdom Singapore Southeast Asia Denmark North America Asia Pacific Europe

INDUSTRY KEYWORDS: Chemicals/Plastics Maritime Logistics/Supply Chain Management Oil/Gas Transport Manufacturing Energy

MEDIA:

Logo
Logo

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 1,043,484 shares of common stock at a purchase price of $17.2499 per share, which equals the public offering price per share of the common stock less the $0.0001 exercise price per share of each pre-funded warrant. The gross proceeds from this offering are expected to be $150.0 million, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics. The offering is expected to close on or about September 17, 2026, subject to customary closing conditions. In addition, Beta Bionics has granted the underwriters for the offering a 30-day option to purchase up to 1,304,348 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Beta Bionics expects to use the net proceeds from this offering for general corporate purposes, which may include costs associated with the commercialization of MintTM, including expansion of Beta Bionics’ manufacturing facilities, research and development and clinical development, investment in product enhancements, potential strategic opportunities and working capital and operating expenses.

J.P. Morgan, Piper Sandler, Wells Fargo Securities and Leerink Partners are acting as the joint book-running managers for the offering.

The shares of common stock and pre-funded warrants described above are being offered by Beta Bionics pursuant to a shelf registration statement on Form S-3 that was filed by Beta Bionics with the Securities and Exchange Commission (SEC) on February 24, 2026 and automatically became effective upon filing. A final prospectus supplement related to the offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus related to this offering, when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at [email protected] and [email protected]; or from Piper Sandler & Co., 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401, Attention: Prospectus Department, by telephone at (800) 747-3924, or by email at [email protected]; or from Wells Fargo Securities, LLC, Attention: Wells Fargo Securities, 90 South 7th Street, 5th Floor, Minneapolis, Minnesota 55402, by telephone at 800-645-3751 (option #5), by email at [email protected]; or from Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, Massachusetts 02109, by telephone at (800) 808-7525, ext. 6105, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD.

Cautionary Note on Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. These statements may be identified by introductory words such as “may,” “expects,” “goal,” “intend,” “will,” “would,” “subject to” or words of similar meaning, or by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements include statements regarding Beta Bionics’ expectations with respect to the completion, timing and size of the public offering, and the use of proceeds from the offering. For such statements, Beta Bionics claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Beta Bionics’ expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, changes in market conditions, the risk that the offering will not be consummated on the timing contemplated or otherwise, and the satisfaction of customary closing conditions related to the offering, as well as the risks and uncertainties discussed in the preliminary prospectus supplement for the offering and other risks and uncertainties disclosed in Beta Bionics’ filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 24, 2026, as updated by its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on July 29, 2026, and other filings that Beta Bionics may make from time to time with the SEC. These forward-looking statements represent Beta Bionics’ judgment as of the time of this release. Beta Bionics disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Investor Relations:

Blake Beber
Head of Investor Relations
[email protected]

Media and Public Relations:

Felicia Sanborn
Vice President of Marketing
[email protected]



Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and approximately 29% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Cogent Communications Holdings, Inc. (“Cogent” or the “Company”) (NasdaqGS: CCOI), if they purchased the Company’s shares between February 29, 2024 and May 1, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Columbia.

What You May Do

If you purchased shares of Cogent as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-ccoi/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by September 21, 2026.

>>>


CLICK HERE


for more information

About the Lawsuit

Cogent and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the most of the purported orders in the Company’s optical wavelength “backlog” were unlikely to ever result in a paid order; (ii) many of the “backlog” customers were unable or unwilling to accept delivery even if timely provision was possible; (iii) as a result of (i)-(ii) above, the Company had materially misrepresented demand for its optical wavelength services and the nature of its “backlog” of wavelength orders; (iv) as a result of (i)-(iii) above, the Company was not on track to achieve its revenue and margin targets and such targets lacked a reasonable basis in objective fact; (v) the Company did not have the financial capacity or business fundamentals to maintain its long-standing dividend policy; and (vi) there was a material, undisclosed risk that Cogent Founder, CEO and Chairman, David Schaeffer, would be forced to sell vast quantities of Cogent stock as a result of his high-risk pledging activities, thereby further depressing the price of the Company’s stock in the event the truth regarding its “backlog,” demand issues, and financial position were ever revealed.

The case is City of Southfield Fire and Police Retirement System v. Cogent Communications Holdings, Inc., No. 26-cv-02609.

>>>To Learn More, Click


HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click


HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



Avis Budget Group, Inc. Notice of September 29, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Avis Budget Group, Inc. (“Avis” or the “Company”) (NasdaqGS: CAR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Avis securities (including those who bought Avis common stock to cover a short position) between February 20, 2025 and April 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Florida.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-car/  

Avis investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-car/ to learn more.

>>>

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Avis and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

According to the complaint, Defendants Pentwater and Halbower engaged in a scheme to manipulate the market for Avis securities. Pentwater, as one of Avis’s largest shareholders — holding an approximate 51% total economic interest in the Company through stock and cash-settled swaps as of March 2026 — allegedly leveraged this position by aggressively purchasing Avis stock during the Class Period. This buying activity triggered unusual volatility and a short squeeze in Avis securities, meaning a rapid surge in the stock price as short sellers bought back shares to cover their losses, which in turn fueled further price increases. The result, according to the complaint, was a significant increase in the value of Pentwater’s Avis holdings.   Avis’s stock price reached a staggering high of $765.94 per share during intraday trading on April 21, an increase of approximately 419% over its $147.52 opening price on April 1, before closing at $713.97 per share. Then, over the following trading sessions, Avis’s share price collapsed by 74.51%, closing at $182.005 per share on April 28, 2026.

The case is Hakimian v. Pentwater Capital Management LP, et al., No. 26-cv-02275.

WHAT TO DO? If you invested in Avis and suffered a loss during the relevant time frame, you have until September 29, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-capr/  

Capricor investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-capr/ to learn more.

>>>

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Capricor and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On July 27, 2026, pre-market, the U.S. Food and Drug Administration (“FDA”) published briefing documents ahead of its July 29 advisory committee meeting to review the Biologics License Application (“BLA”) for the Company’s lead product candidate, Deramiocel, finding that the Company made changes to the pre-specified statistical analysis plan (“SAP”) and that the final version “was not submitted to FDA for review prior to BLA submission and was not discussed and consequently not agreed upon.” Importantly, the final SAP was finalized just one day before the data was unblinded. The FDA disagreed with the changes made to the SAP, explaining that converting raw change to percent change and back again added unnecessary complexity and undermined accuracy, without scientific justification for doing so. As a result, the FDA stated that it “considers [Capricor’s] analyses based on the post-study SAP versions to be post-hoc and exploratory.” According to the briefing documents, the benefit-risk profile for deramiocel looked unfavorable given the lack of evidence supporting its effectiveness.

On this news, Capricor’s stock fell $12.70, or 64%, to close at $7.00 per share on July 27, 2026, on unusually heavy trading volume

The case is Nkamga v. Capricor Therapeutics, Inc., et al., No. 3:26-cv-04385.

WHAT TO DO? If you invested in Capricor and suffered a loss during the relevant time frame, you have until September 28, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



Semtech SurgeSwitch Protects Cobots from Surge and ESD

Semtech SurgeSwitch Protects Cobots from Surge and ESD

TDS2621LP holds near-constant clamping voltage from 0 A to 24 A in an ultra-compact 1.6 mm2 footprint for 24 V DC industrial robotics

CAMARILLO, Calif.–(BUSINESS WIRE)–Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductors powering AI data center networking and intelligent, connected Internet of Things (“IoT”) devices worldwide, today announced TDS2621LP, the latest addition to its SurgeSwitch® family. Purpose built for 24 V DC power buses in industrial robotics, collaborative robots (cobots) and automated manufacturing, TDS2621LP delivers near-constant clamping voltage, IEC 61000-4-5 surge compliance and a 1.6 mm2 footprint, replacing bulkier conventional industrial packaged protection devices.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915242022/en/

Purpose built for 24 V DC power buses in industrial robotics, collaborative robots (cobots) and automated manufacturing, Semtech's TDS2621LP delivers near-constant clamping voltage, IEC 61000-4-5 surge compliance and a 1.6 mm² footprint.

Purpose built for 24 V DC power buses in industrial robotics, collaborative robots (cobots) and automated manufacturing, Semtech’s TDS2621LP delivers near-constant clamping voltage, IEC 61000-4-5 surge compliance and a 1.6 mm² footprint.

As robotic systems shrink and move closer to humans on the factory floor, safety-critical I/O modules face a harsher Electrostatic Discharge (ESD) and surge environment. Inductive loads such as servo motors, electromagnetic brakes and pneumatic solenoids switching on and off thousands of times per shift generate high-energy transients directly on the 24 V DC bus feeding sensitive control circuitry. Conventional Transient Voltage Suppression (TVS) diodes see clamping voltage rise with peak pulse current and shift across the industrial temperature range, leaving protection margins unpredictable and requiring designers to over-specify downstream components.

“As robots and cobots pack more electronics into smaller spaces, critical margin for protection error shrinks while transient energy on the 24 V bus grows,” said Tamir Reshef, vice president of marketing and applications, analog and mixed signal products group at Semtech. “TDS2621LP solves density and footprint issues with near-constant clamping voltage at full pulse current, offering robotics system designers predictable headroom.”

TDS2621LP, built on Semtech’s proven SurgeSwitch architecture, advances the conventional PN-junction approach with a surge-rated FET operating as a precision voltage-controlled switch. Unlike conventional TVS diodes, SurgeSwitch offers uniform clamping voltage of 35 V at 24 A (8/20 μs) with a dynamic resistance of just 32 mΩ across the full pulse current range.

Target Applications

  • Cobot joint electronics and controller boards

  • Industrial robot input line protection

  • Autonomous mobile robot (AMR) and automated guided vehicle (AGV) power buses

  • PLC I/O modules, fieldbus interfaces (PROFIBUS, EtherCAT, IO-Link) and distributed control cabinets

  • 24 V actuator and solenoid valve driver boards in factory automation

  • Industrial sensor power lines and smart sensor nodes

  • VBUS power lines in USB Type-C industrial ports

  • IoT edge devices operating on 24 V DC infrastructure

Key Specifications

  • Maximum working voltage: 26.4 V (matched to the IEC upper tolerance band for 24 V DC systems)

  • Peak pulse current: 24 A (tp = 8/20 μs) per IEC 61000-4-5

  • Maximum clamping voltage: 35 V at 24 A

  • Dynamic resistance: 32 mΩ

  • Package: DFN 1.6 mm2 footprint, 2-Lead

Availability

TDS2621LP is available now in production quantities, supplied in 7-inch tape-and-reel, 3,000 units per reel. Samples and evaluation support are available through Semtech’s authorized distribution partners and for direct purchase on semtech.com. For design-in support, application notes and reference layout guidance, learn more at TDS2621LP.

Customers and partners are invited to visit Semtech at Booth #H3.G11 during Electronica India 2026, Sept. 16–18, in Bengaluru, India, to learn more about the portfolio and meet with Semtech’s technical experts.

About Semtech

Semtech Corporation (Nasdaq: SMTC) is a leading provider of high-performance semiconductors powering AI data center networking and intelligent, connected IoT devices worldwide. Our global teams are committed to empowering solution architects and application developers to develop breakthrough products for the infrastructure, industrial and consumer markets. To learn more about Semtech technology, visit us at Semtech.com or follow us on LinkedIn or X.

Semtech, the Semtech logo and SurgeSwitch are registered trademarks or service marks of Semtech Corporation or its subsidiaries. All other trademarks, service marks and trade names mentioned in this press release are the property of their respective owners.

SMTC-P

Michelle Lozada, [email protected]

KEYWORDS: United States India North America Asia Pacific California

INDUSTRY KEYWORDS: Data Management Technology Manufacturing IOT (Internet of Things) Robotics Semiconductor Other Manufacturing Artificial Intelligence Networks Internet Hardware

MEDIA:

Photo
Photo
Purpose built for 24 V DC power buses in industrial robotics, collaborative robots (cobots) and automated manufacturing, Semtech’s TDS2621LP delivers near-constant clamping voltage, IEC 61000-4-5 surge compliance and a 1.6 mm² footprint.
Logo
Logo

Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK CITY and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Wix.com Ltd. (“Wix” or the “Company”) (NasdaqGS: WIX) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Wix securities between February 19, 2025 and May 12, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-wix/

Wix investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-wix/ to learn more.

>>>

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Wix and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

The alleged false and misleading statements and/or omissions include, but are not limited to, that: (i) the Company had overstated the competitiveness and performance of its AI product offerings relative to those offered by other companies; (ii) the Company had understated the costs associated with developing and promoting its AI product offerings; (iii) accordingly, Defendants overstated the commercial and financial benefits of Wix’s AI product offerings; and (iv) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

The case is Yappi v. Wix.com Ltd., et al., No. 26-cv-08852.

WHAT TO DO? If you invested in Wix and suffered a loss during the relevant time frame, you have until September 22, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



York Space Systems, Inc. Notice of October 30, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK CITY and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in York Space Systems, Inc. (“York Space Systems” or the “Company”) (NYSE: YSS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired (a) York Space Systems common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2026 initial public offering (“IPO” or the “Offering”); and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nyse-yss/   

York Space Systems investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-yss/ to learn more.

>>>

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

Specifically, the lawsuit alleges that Defendants failed to disclose to investors that: (i) the Company’s onboard mission and payload software was not fully functional before satellites were launched; (ii) this ongoing trend presented a risk to the Company’s contracts with the Pentagon’s Space Development Agency (“SDA”), deceived the SDA with false advertising to win its contracts, cut corners, and delivered satellites whose mission-critical-software was not completed; and (iii) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

The case is Ianelli v. York Space Systems, Inc. et al., 26-cv-04074.

WHAT TO DO? If you invested in York Space and suffered a loss during the relevant time frame, you have until October 30, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn